Belle

What it is

Patients complete an online application; a clinician decides whether to prescribe compounded semaglutide or tirzepatide.

The site says dose increases, nutrition guidance and nurse support are included, and the price is the same at every dose.

It also lists NAD+, sermorelin, glutathione and other wellness products.

Prescribes: Compounded semaglutide and tirzepatide; site says these are compounded in US pharmacies and not FDA-evaluated

What it costs

Insurance: Site says no insurance required; FSA/HSA and financing offered

Prices change often. Check joinbelle.com before you sign up.

By the numbers

• Trustpilot 4.5/5 from 1,473 reviews (6% 1-star; checked 2026-10-15).4

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Reviewers often praise responsive support, fast shipping and affordable pricing3
• Some reviewers find vial labels and dosing instructions hard to understand3
• Belle became widely discussed in r/tirzepatidecompound in 2026 for buying a large supply of compounded tirzepatide from a well-regarded outsourcing pharmacy, with members debating its high regular prices and later discounts (such as $149 for 60 mg in May 2026).56
• In October 2026 members reported orders for a specific pharmacy's product being filled with a different formulation from another pharmacy without notice; another member said Belle told them up front it could not guarantee that pharmacy.7
• Members noted that a sister brand, Crossing, was folded into Belle in July 2026 after about a month, and some reported auto-renewal or post-cancellation charges.89
• Longer-term users praise fast shipping and Belle's weekly live nutrition sessions; Trustpilot reviewers similarly praise responsive support and delivery, with complaints about confusing vial labels and dosing instructions.54

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Feb 2026
   FDA

   FDA sent a warning letter stating that pictured labels naming Belle implied it was the compounder of its compounded semaglutide and tirzepatide, rendering the products misbranded under sections 502(a) and 502(bb) of the FD&C Act.1